Could GLP-1 Therapy Be Right for You?

6 quick questions + BMI check · Takes about 2 minutes

For informational purposes only — not medical advice.

Medical Disclaimer: This assessment is for educational and informational purposes only. It is not a diagnostic tool and does not provide medical advice, diagnosis, or treatment recommendations. Always consult a qualified healthcare provider before making any health decisions.

Step 1: Check Your BMI

GLP-1 medications are typically prescribed for individuals with a BMI of 27+ (with comorbidities) or 30+.

1

What is your primary health goal?

2

Have you been diagnosed with or are you managing any of the following?

3

How would you describe your experience with diet and exercise for weight management?

4

How comfortable are you with weekly injectable medications?

5

Do you have a healthcare provider you can discuss GLP-1 therapy with?

6

What matters most to you when considering a new treatment?

Suggested Reading

Medical Disclaimer: This quiz is for educational and informational purposes only. It does not provide medical advice, diagnosis, or treatment recommendations. Your results are intended to help you find relevant reading material — they are not a clinical assessment and should not be used to make health decisions. GLP-1 receptor agonists are prescription medications that require evaluation by a qualified healthcare provider. Always consult your doctor before starting any medication or therapy.

Popular telehealth providers in this space

Disclosure: The links below are affiliate links — if you click through and make a purchase, GLPbase may earn a small commission at no additional cost to you. This section does not constitute medical advice or a recommendation to seek treatment. Any healthcare decisions are solely between you and your provider. These links do not affect the article above, which is independently researched and written before any affiliate links are added. Our editorial team does not receive commissions, and our analysis is never influenced by affiliate partnerships. For more details, see our Editorial Policy.